News blog

US Court upholds Myriad’s breast cancer gene patents

The biotechnology industry breathed a deep sign of relief today, as a US Appeals court upheld a company’s controversial patents on genes linked to breast cancer.

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE